These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 21474904)

  • 1. Presence of neck pain may delay migraine treatment.
    Calhoun AH; Ford S; Pruitt AP
    Postgrad Med; 2011 Mar; 123(2):163-8. PubMed ID: 21474904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of neck pain in migraine.
    Calhoun AH; Ford S; Millen C; Finkel AG; Truong Y; Nie Y
    Headache; 2010 Sep; 50(8):1273-7. PubMed ID: 20100298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
    Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain characteristics of the acute migraine attack.
    Kelman L
    Headache; 2006 Jun; 46(6):942-53. PubMed ID: 16732840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neck pain disability is related to the frequency of migraine attacks: a cross-sectional study.
    Florencio LL; Chaves TC; Carvalho GF; Gonçalves MC; Casimiro EC; Dach F; Bigal ME; Bevilaqua-Grossi D
    Headache; 2014; 54(7):1203-10. PubMed ID: 24863346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, placebo-controlled, crossover study of early-intervention with sumatriptan 85/naproxen sodium 500 in (truly) episodic migraine: what's neck pain got to do with it?
    Calhoun AH; Ford S
    Postgrad Med; 2014 Mar; 126(2):86-90. PubMed ID: 24685971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
    Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
    Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The point prevalence of dizziness or vertigo in migraine--and factors that influence presentation.
    Calhoun AH; Ford S; Pruitt AP; Fisher KG
    Headache; 2011 Oct; 51(9):1388-92. PubMed ID: 21797862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
    Derosier F; Sheftell F; Silberstein S; Cady R; Ruoff G; Krishen A; Peykamian M
    Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between neck pain disability and cervical range of motion in patients with episodic and chronic migraine: a cross-sectional study.
    Carvalho GF; Chaves TC; Gonçalves MC; Florencio LL; Braz CA; Dach F; Fernández de Las Peñas C; Bevilaqua-Grossi D
    J Manipulative Physiol Ther; 2014; 37(9):641-6. PubMed ID: 25284740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does early migraine treatment shorten time to headache peak and reduce its severity?
    Hu XH; Ng-Mak D; Cady R
    Headache; 2008 Jun; 48(6):914-20. PubMed ID: 18005142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signs of temporomandibular disorders in migraine patients: a prospective, controlled study.
    Stuginski-Barbosa J; Macedo HR; Bigal ME; Speciali JG
    Clin J Pain; 2010 Jun; 26(5):418-21. PubMed ID: 20473049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
    Raggi A; Leonardi M; Bussone G; D'Amico D
    Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
    Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
    Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allodynia in migraine: association with comorbid pain conditions.
    Tietjen GE; Brandes JL; Peterlin BL; Eloff A; Dafer RM; Stein MR; Drexler E; Martin VT; Hutchinson S; Aurora SK; Recober A; Herial NA; Utley C; White L; Khuder SA
    Headache; 2009 Oct; 49(9):1333-44. PubMed ID: 19788473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
    Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
    Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of migraine is a predictor for response to botulinum toxin type A.
    Eross EJ; Gladstone JP; Lewis S; Rogers R; Dodick DW
    Headache; 2005 Apr; 45(4):308-14. PubMed ID: 15836566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
    Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM
    Headache; 2011; 51(7):1058-77. PubMed ID: 21762134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Migraine changes with age: IMPACT on migraine classification.
    Kelman L
    Headache; 2006; 46(7):1161-71. PubMed ID: 16866720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.